Detection of aberrant protein phosphorylation in cancer using direct gold-protein affinity interactions

Mostak Ahmed1, Laura G Carrascosa1, Abu Ali Ibn Sina1

  • 1Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Corner College and Cooper Roads (Bldg 75), Brisbane QLD 4072, Australia.

Biosensors & Bioelectronics
|December 17, 2016
PubMed

Insights

This study introduces a novel electrochemical method to detect aberrant protein phosphorylation in cancer by observing changes in gold surface interactions. This approach offers a simpler alternative for monitoring cancer cell sensitivity to drugs like tyrosine kinase inhibitors (TKIs).

Area of Science:

  • Biochemistry
  • Oncology
  • Electrochemistry

Background:

  • Protein phosphorylation is a key post-translational modification regulating protein function, often dysregulated in cancer.
  • Altered protein conformation due to phosphorylation can affect interactions with surfaces, including gold.
  • Aberrant phosphorylation of Epidermal Growth Factor Receptor (EGFR) is implicated in lung cancer progression.

Purpose of the Study:

  • To develop a simple electrochemical method for detecting aberrant EGFR phosphorylation in lung cancer.
  • To assess the utility of this method in monitoring cancer cell sensitivity to tyrosine kinase inhibitors (TKIs).

Main Methods:

  • Exploiting altered protein-gold surface adsorption due to phosphorylation-induced conformational changes.
  • Developing an electrochemical detection strategy for EGFR phosphorylation.
  • Utilizing purified EGFR protein at low concentrations (10ng/µL).

Main Results:

  • Demonstrated a novel electrochemical method for detecting aberrant EGFR phosphorylation in lung cancer cell lines.
  • Successfully monitored cancer cell sensitivity to TKIs using the developed method.
  • The method requires minimal purified EGFR protein and avoids the need for phospho-specific antibodies.

Conclusions:

  • The developed electrochemical strategy offers a direct gold-protein affinity-based detection of aberrant protein phosphorylation.
  • This method provides a potential alternative to mass spectrometry and antibody-dependent assays for cancer biomarker detection.
  • The approach facilitates monitoring of therapeutic responses to TKIs in lung cancer.